| Functional properties of leptin receptor isoforms: internalization and degradation of leptin and ligand-induced receptor downregulation. S Uotani, C Bjørbaek, J Tornøe, JS Flier Diabetes 48 (2), 279-286, 1999 | 343 | 1999 |
| Transcellular transport of leptin by the short leptin receptor isoform ObRa in Madin-Darby Canine Kidney cells SM Hileman, J Tornøe, JS Flier, C Bjørbæk Endocrinology 141 (6), 1955-1961, 2000 | 192 | 2000 |
| Targeted delivery of nerve growth factor via encapsulated cell biodelivery in Alzheimer disease: a technology platform for restorative neurosurgery LU Wahlberg, G Lind, PM Almqvist, P Kusk, J Tornøe, B Juliusson, ... Journal of neurosurgery 117 (2), 340-347, 2012 | 131 | 2012 |
| Generation of a synthetic mammalian promoter library by modification of sequences spacing transcription factor binding sites J Tornøe, P Kusk, TE Johansen, PR Jensen Gene 297 (1-2), 21-32, 2002 | 107 | 2002 |
| Efficient in vivo protection of nigral dopaminergic neurons by lentiviral gene transfer of a modified Neurturin construct L Fjord-Larsen, JL Johansen, P Kusk, J Tornøe, M Grønborg, ... Experimental neurology 195 (1), 49-60, 2005 | 106 | 2005 |
| Encapsulated cell therapy for neurodegenerative diseases: from promise to product DF Emerich, G Orive, C Thanos, J Tornoe, LU Wahlberg Advanced drug delivery reviews 67, 131-141, 2014 | 104 | 2014 |
| Generation and characterization of immortalized rat pancreatic stellate cells G Sparmann, C Hohenadl, J Tornøe, R Jaster, B Fitzner, D Koczan, ... American Journal of Physiology-Gastrointestinal and Liver Physiology 287 (1 …, 2004 | 79 | 2004 |
| Long-term delivery of nerve growth factor by encapsulated cell biodelivery in the Göttingen minipig basal forebrain L Fjord-Larsen, P Kusk, J Tornøe, B Juliusson, M Torp, CR Bjarkam, ... Molecular therapy 18 (12), 2164-2172, 2010 | 73 | 2010 |
| Increased encapsulated cell biodelivery of nerve growth factor in the brain by transposon-mediated gene transfer L Fjord-Larsen, P Kusk, DF Emerich, C Thanos, M Torp, B Bintz, J Tornøe, ... Gene therapy 19 (10), 1010-1017, 2012 | 48 | 2012 |
| Increased in vitro and in vivo transgene expression levels mediated through cis‐acting elements J Johansen, J Tornøe, A Møller, TE Johansen The Journal of Gene Medicine: A cross‐disciplinary journal for research on …, 2003 | 28 | 2003 |
| Encapsulated cell device approach for combined electrical stimulation and neurotrophic treatment of the deaf cochlea WS Konerding, H Janssen, P Hubka, J Tornøe, P Mistrik, L Wahlberg, ... Hearing Research 350, 110-121, 2017 | 25 | 2017 |
| Secretion of neublastin LU Wahlberg, M Gronborg, P Kusk, J Tornoe US Patent 7,601,518, 2009 | 21 | 2009 |
| A new versatile and compact lentiviral vector JL Johansen, L Dagø, J Tornøe, C Rosenblad, P Kusk Molecular biotechnology 29, 47-55, 2005 | 21 | 2005 |
| Encapsulated cell-based biodelivery of meteorin is neuroprotective in the quinolinic acid rat model of neurodegenerative disease J Tornøe, M Torp, JR Jørgensen, DF Emerich, C Thanos, B Bintz, ... Restorative neurology and neuroscience 30 (3), 225-236, 2012 | 20 | 2012 |
| Unilateral ex vivo gene therapy by GDNF in epileptic rats A Nanobashvili, E Melin, D Emerich, J Tornøe, M Simonato, L Wahlberg, ... Gene therapy 26 (3), 65-74, 2019 | 17 | 2019 |
| The feasibility of an encapsulated cell approach in an animal deafness model A Fransson, J Tornøe, LU Wahlberg, M Ulfendahl Journal of controlled release 270, 275-281, 2018 | 13 | 2018 |
| In vivo gene therapy of parkinson's disease J Tornøe, C Rosenblad, L Wahlberg US Patent App. 10/520,500, 2006 | 13 | 2006 |
| Human Therapeutic Cells Secreting Nerve Growth Factor J Tornoe, P Kusk, L Wahlberg US Patent App. 10/585,811, 2008 | 11 | 2008 |
| A surgical device for minimally invasive implantation of experimental deep brain stimulation leads in large research animals KS Ettrup, J Tornøe, JC Sørensen, CR Bjarkam Journal of neuroscience methods 200 (1), 41-46, 2011 | 10 | 2011 |
| JeT promoter J Tornøe US Patent 6,555,674, 2003 | 8 | 2003 |
